Free Trial

NortonLifeLock (NLOK) Competitors

NortonLifeLock logo
$27.52 +0.20 (+0.73%)
As of 01/17/2025

NLOK vs. BTX, and ALFIW

Should you be buying NortonLifeLock stock or one of its competitors? The main competitors of NortonLifeLock include Brooklyn ImmunoTherapeutics (BTX), and Alfi (ALFIW). These companies are all part of the "information" sector.

NortonLifeLock vs.

Brooklyn ImmunoTherapeutics (NYSE:BTX) and NortonLifeLock (NASDAQ:NLOK) are both information companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, community ranking, risk, media sentiment, profitability and institutional ownership.

Brooklyn ImmunoTherapeutics has a beta of 4.61, meaning that its share price is 361% more volatile than the S&P 500. Comparatively, NortonLifeLock has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500.

26.0% of Brooklyn ImmunoTherapeutics shares are owned by institutional investors. Comparatively, 94.9% of NortonLifeLock shares are owned by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are owned by company insiders. Comparatively, 3.3% of NortonLifeLock shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Brooklyn ImmunoTherapeuticsN/A N/A N/A
NortonLifeLock N/A N/A N/A

NortonLifeLock received 85 more outperform votes than Brooklyn ImmunoTherapeutics when rated by MarketBeat users. Likewise, 100.00% of users gave NortonLifeLock an outperform vote while only 0.00% of users gave Brooklyn ImmunoTherapeutics an outperform vote.

CompanyUnderperformOutperform
Brooklyn ImmunoTherapeuticsOutperform Votes
No Votes
Underperform Votes
103
100.00%
NortonLifeLockOutperform Votes
85
100.00%
Underperform Votes
No Votes

In the previous week, NortonLifeLock had 1 more articles in the media than Brooklyn ImmunoTherapeutics. MarketBeat recorded 2 mentions for NortonLifeLock and 1 mentions for Brooklyn ImmunoTherapeutics. NortonLifeLock's average media sentiment score of 0.30 beat Brooklyn ImmunoTherapeutics' score of 0.00 indicating that NortonLifeLock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Brooklyn ImmunoTherapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NortonLifeLock
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NortonLifeLock has higher revenue and earnings than Brooklyn ImmunoTherapeutics. Brooklyn ImmunoTherapeutics is trading at a lower price-to-earnings ratio than NortonLifeLock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-0.19
NortonLifeLock$2.82B5.58$817.05M$1.4319.24

Summary

NortonLifeLock beats Brooklyn ImmunoTherapeutics on 8 of the 10 factors compared between the two stocks.

Get NortonLifeLock News Delivered to You Automatically

Sign up to receive the latest news and ratings for NLOK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NLOK vs. The Competition

MetricNortonLifeLockData Processing, Hosting, and Related Services IndustryInformation SectorNASDAQ Exchange
Market Cap$15.72B$15.72B$5.27B$9.14B
Dividend Yield2.31%2.31%3.69%4.02%
P/E Ratio19.249.628.2817.36
Price / Sales5.585.585.5877.11
Price / CashN/AN/AN/A35.97
Price / BookN/AN/AN/A4.79
Net Income$817.05MN/AN/A$225.00M
7 Day Performance2.30%1.15%6.15%2.62%
1 Month Performance0.26%0.13%10.12%3.81%
1 Year Performance17.21%8.60%-8.63%20.10%

NortonLifeLock Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NLOK
NortonLifeLock
1.502 of 5 stars
$27.52
+0.7%
N/A+17.2%$15.72B$2.82B19.24N/A
BTX
Brooklyn ImmunoTherapeutics
N/A$0.30
-7.2%
N/A-69.8%$17.65MN/A-0.13N/AGap Down
ALFIW
Alfi
N/AN/AN/AN/A$0.00$200,684.000.0040

Related Companies and Tools


This page (NASDAQ:NLOK) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners